130 related articles for article (PubMed ID: 15055521)
1. Cdk5/p35 expression in the mouse ovary.
Lee KY; Rosales JL; Lee BC; Chung SH; Fukui Y; Lee NS; Lee KY; Jeong YG
Mol Cells; 2004 Feb; 17(1):17-22. PubMed ID: 15055521
[TBL] [Abstract][Full Text] [Related]
2. Expression of Cdk5, p35, and Cdk5-associated kinase activity in the developing rat lens.
Gao CY; Zakeri Z; Zhu Y; He H; Zelenka PS
Dev Genet; 1997; 20(3):267-75. PubMed ID: 9216066
[TBL] [Abstract][Full Text] [Related]
3. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice.
Van den Haute C; Spittaels K; Van Dorpe J; Lasrado R; Vandezande K; Laenen I; Geerts H; Van Leuven F
Neurobiol Dis; 2001 Feb; 8(1):32-44. PubMed ID: 11162238
[TBL] [Abstract][Full Text] [Related]
5. Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35.
Cheng K; Li Z; Fu WY; Wang JH; Fu AK; Ip NY
J Biol Chem; 2002 Aug; 277(35):31988-93. PubMed ID: 12084709
[TBL] [Abstract][Full Text] [Related]
6. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
Hallows JL; Chen K; DePinho RA; Vincent I
J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648
[TBL] [Abstract][Full Text] [Related]
7. Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells.
Catania A; Urban S; Yan E; Hao C; Barron G; Allalunis-Turner J
Neuro Oncol; 2001 Apr; 3(2):89-98. PubMed ID: 11296485
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis.
Zheng YL; Zhang X; Fu HX; Guo M; Shukla V; Amin ND; E J; Bao L; Luo HY; Li B; Lu XH; Gao YC
PLoS One; 2016; 11(8):e0160252. PubMed ID: 27479491
[TBL] [Abstract][Full Text] [Related]
9. Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain.
Ohshima T; Ogawa M; Veeranna ; Hirasawa M; Longenecker G; Ishiguro K; Pant HC; Brady RO; Kulkarni AB; Mikoshiba K
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2764-9. PubMed ID: 11226314
[TBL] [Abstract][Full Text] [Related]
10. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation.
Nikolic M; Dudek H; Kwon YT; Ramos YF; Tsai LH
Genes Dev; 1996 Apr; 10(7):816-25. PubMed ID: 8846918
[TBL] [Abstract][Full Text] [Related]
11. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death.
O'Hare MJ; Kushwaha N; Zhang Y; Aleyasin H; Callaghan SM; Slack RS; Albert PR; Vincent I; Park DS
J Neurosci; 2005 Sep; 25(39):8954-66. PubMed ID: 16192386
[TBL] [Abstract][Full Text] [Related]
13. The protein SET binds the neuronal Cdk5 activator p35nck5a and modulates Cdk5/p35nck5a activity.
Qu D; Li Q; Lim HY; Cheung NS; Li R; Wang JH; Qi RZ
J Biol Chem; 2002 Mar; 277(9):7324-32. PubMed ID: 11741927
[TBL] [Abstract][Full Text] [Related]
14. Regulation of contextual fear conditioning by baseline and inducible septo-hippocampal cyclin-dependent kinase 5.
Fischer A; Sananbenesi F; Schrick C; Spiess J; Radulovic J
Neuropharmacology; 2003 Jun; 44(8):1089-99. PubMed ID: 12763101
[TBL] [Abstract][Full Text] [Related]
15. Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death.
Ahuja HS; Zhu Y; Zakeri Z
Dev Genet; 1997; 21(4):258-67. PubMed ID: 9438340
[TBL] [Abstract][Full Text] [Related]
16. The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning.
Philpott A; Porro EB; Kirschner MW; Tsai LH
Genes Dev; 1997 Jun; 11(11):1409-21. PubMed ID: 9192869
[TBL] [Abstract][Full Text] [Related]
17. Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells.
Ubeda M; Kemp DM; Habener JF
Endocrinology; 2004 Jun; 145(6):3023-31. PubMed ID: 14976144
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by Cdk5 and p35.
Sun D; Leung CL; Liem RK
J Biol Chem; 1996 Jun; 271(24):14245-51. PubMed ID: 8662984
[TBL] [Abstract][Full Text] [Related]
19. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
[TBL] [Abstract][Full Text] [Related]
20. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
